BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Telerik Inc.//Sitefinity CMS 14.4//EN
BEGIN:VTIMEZONE
TZID:Pacific Standard Time
BEGIN:STANDARD
DTSTART:20251102T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=11
TZNAME:Pacific Standard Time
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250301T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3
TZNAME:Pacific Daylight Time
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:Address: 939 Laurel Street\, Suite C\, San Carlos\, CA 94070\n\
 nTOPICMRONJ: A Practical Guide to Understanding Risks\, Recognition and Tr
 eatmentSPEAKERDominique MahalCONTINUING EDUCATION2 CE Units (Core) Medicat
 ion-related osteonecrosis of the jaw (MRONJ) is an increasingly relevant c
 ondition as more patients present with histories of antiresorptive and ant
 iangiogenic therapy. For the general dentist\, early recognition and appro
 priate management can significantly impact patient outcomes and quality of
  life.This lecture will provide a practical\, case-based approach to ident
 ifying at-riskpatients\, understanding disease progression\, and confident
 ly navigating communication with the patient’s medical team. Attendees wil
 l leave with clear strategies to prevent complications\, manage MRONJ at v
 arious stages\, and effectively counsel patients in everyday clinical prac
 tice.Course Objectives:Identify medication classes associated with MRONJRe
 cognize patient risk factors and clinical presentationsDescribe the stagin
 g of MRONJ and treatment planning implicationsApply evidence based strateg
 ies for prevention and treatmentCounsel patients with confidenceSpeaker Bi
 oDominique Mahal\, DDS is a Board-Certified Oral &amp\; Maxillofacial Surg
 eon. She completed her DDS degree at USC School of Dentistry and continued
  her training at the UCSF Fresno OMFSprogram\, where she had extensive spe
 cialized education in head and neck oncology. This quipped Dr. Mahal with 
 a strong foundation in the management of medication-related osteonecrosis 
 of the jaw (MRONJ) across all stages. She also encounters and treats these
  complex conditions while on hospital call\, and in private practice.  
DTEND:20261204T043000Z
DTSTAMP:20260620T182739Z
DTSTART:20261204T023000Z
LOCATION:939 Laurel Street\, Suite C\, San Carlos\, CA 94070
SEQUENCE:0
SUMMARY:MRONJ
UID:RFCALITEM639175768599108799
X-ALT-DESC;FMTTYPE=text/html:<strong>Address:</strong> 939 Laurel Street\, 
 Suite C\, San Carlos\, CA 94070<br><br><p><a href="https://www.bcpay.onlin
 e/SMCDS/register.php?Id=835"><img src="https://www.smcds.com/images/localc
 asanmateocountycalifornialibraries/private-library/general-images/register
 _button.jpg?sfvrsn=a8948f8b_1" alt=""></a><br></p><p><strong>TOPIC</strong
 ><br>MRONJ: A Practical Guide to Understanding Risks\, Recognition and Tre
 atment</p><p><strong>SPEAKER</strong><br>Dominique Mahal<strong><br></stro
 ng></p><p><strong><br></strong><strong></strong><strong>CONTINUING EDUCATI
 ON</strong><br>2 CE Units (Core)</p><p><strong>&nbsp\;</strong></p>Medicat
 ion-related osteonecrosis of the jaw (MRONJ) is an increasingly relevant c
 ondition as more patients present with histories of antiresorptive and ant
 iangiogenic therapy. For the general dentist\, early recognition and appro
 priate management can significantly impact patient outcomes and quality of
  life.<br>This lecture will provide a practical\, case-based approach to i
 dentifying at-risk<br>patients\, understanding disease progression\, and c
 onfidently navigating communication with the patient’s medical team. Atten
 dees will leave with clear strategies to prevent complications\, manage MR
 ONJ at various stages\, and effectively counsel patients in everyday clini
 cal practice.<p><br></p><p><strong>Course Objectives</strong>:</p><ul><li>
 Identify medication classes associated with MRONJ</li><li>Recognize patien
 t risk factors and clinical presentations</li><li>Describe the staging of 
 MRONJ and treatment planning implications</li><li>Apply evidence based str
 ategies for prevention and treatment</li><li>Counsel patients with confide
 nce</li></ul><p><br><br></p><p><strong>Speaker Bio</strong></p><p><strong>
 Dominique Mahal\, DDS</strong> is a Board-Certified Oral &amp\; Maxillofac
 ial&nbsp\;Surgeon. <br>She completed her DDS degree at USC School of Denti
 stry and continued her training at the UCSF Fresno OMFS<br>program\, where
  she had extensive specialized education in head and neck oncology. This q
 uipped Dr. Mahal with a strong foundation in the management of medication-
 related osteonecrosis of the jaw (MRONJ) across all stages. She also encou
 nters and treats these complex conditions while on hospital call\, and in 
 private practice.</p><div id="comp-l309r3qw__item-j9r9uz7e" data-testid="r
 ichTextElement"><p>&nbsp\;</p><p>&nbsp\;</p></div>
END:VEVENT
END:VCALENDAR
